Growth Stocks Perking Up
Back in our younger days when we were first learning the market’s inner workings, we viewed the stock market as relatively uniform, even on a short-term basis. Obviously, there were times when divergences popped up (usually near market tops), but the...
Read More
From Cabot Growth Investor
Beyond the action of growth stocks, the general market looks good, with the trends continuing to point up—though, short term, it could be a bit too good, with little to worry about (Fed, trade, economy) and with this week’s new high...
Read More
The stock market recovery from the Q4 2018 cratering is now complete. Where do stocks go from here? The last three recoveries give us some guidance.
Read More
Exploit the Accelerating Technological Revolution
We have a tendency to focus on our everyday lives without truly appreciating how the world is changing around us. But understanding the tectonic shifts outside of our near-term consciousness is crucial to successful investing.
I realized the other day I’ve...
Read More
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
It's not entirely unusual for a new CEO at a company to change the dividend policy due to having a different idea of how the company should be using its cash flow.
Read More
There are three changes to the portfolio today.
Read More
McDonald's isn't the dominant growth story it once was. But McDonald's stock continues to outperform, and is coming off an impressive correction-bucking stretch.
Read More
Two stocks are moving up and a third stock is moving from Buy to Strong Buy.
Read More
Stock Recommendation Tracker
By request, we have added a new feature to your Cabot Prime Weekly Summary—the Stock Recommendation Tracker. It is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see stocks...
Read More
Stock Recommendation Tracker
By request, we have added a new feature to your Cabot Prime Weekly Summary—the Stock Recommendation Tracker. It is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see stocks...
Read More
Prepare yourself for more ups and downs in our medtech & biotech stocks if this debate heats up. I’m not planning to step out of the space since I think this will pass and we can still do quite well with these types stocks.
...
Read More
From a top-down perspective, the market is still looking good, as both the intermediate- and longer-term trends are up and the vast majority of stocks (and leading stocks) are still in uptrends.
Read More
The overall market remains in good shape, with both of our trend-following indicators—the Cabot Tides (intermediate-term) and Cabot Trend Lines (longer-term)—currently pointing up. We’re still keeping an eye on small-cap indexes, which have still not eclipsed their late February peaks, as well as Nasdaq,...
Read More
Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More
Looking at the revenues of the 14 companies in our Marijuana Portfolio, the average growth rate in the latest quarter, relative to the previous year, was 409%. The median, for you statistical fans, was 255%. This is one fast-growing sector!
Read More
Crista has several portfolio updates and changes today.
Read More
The new all time high is a significant milestone. Although the S&P 500 hasn’t hit new highs quite yet it is only just about .01% from the mark. The new high is significant because it negates any possibility that we have been in bear...
Read More
After dipping as low as $42, crude oil prices are back near $59 a barrel. These three oil ETFs are an efficient way to play the latest energy mini-rally.
Read More
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
